Aims: Next to patient characteristics, the lack of a standardised approach for bioresorbable vascular scaffold (BVS) implantation is perceived as a potential explanation for the heterogen
Corrado Tamburino1, MD, PhD; Azeem Latib2, MD; Robert-Jan van Geuns3, MD; Manel Sabate4, MD; Julinda Mehilli5, MD; Tommaso Gori6, MD, PhD; Stephan Achenbach7, MD; Manuel Pan Alvarez8, MD; Holger Nef9, MD; Maciej Lesiak10, MD; Carlo Di Mario11, MD; Antonio Colombo2, MD; Christoph K. Naber12, MD; Giuseppe Caramanno13, MD; Piera Capranzano
1. Ferrarotto Hospital, University of Catania, Catania, Italy; 2. EMO-GVM Centro Cuore and San Raffaele Hospitals, Milan, Italy; 3. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; 4. Department of Cardiology, Thorax Institute
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
bioresorbable vascular scaffoldconsensus document
Read next articleLessons from the real bench: non-BRS